妊娠糖尿病查方面的进展:新兴趋势和未来方向
Didem Kaymak1, Ayse Seval Ozgu-Erdinc2
1Department of Perinatology, Istanbul Education and Research Hospital, Istanbul 34098, Türkiye.
World journal of diabetes
|October 20, 2025
概括
怀孕期糖尿病 (GDM) 的诊断和预测正在通过新的生物标志物和机器学习得到改善. 早期识别和个性化策略是减少母亲和新生儿风险的关键.
科学领域:
- 生殖医学 生殖医学
- 代谢障碍 代谢障碍 代谢障碍
- 生物标志物发现发现
背景情况:
- 孕期糖尿病 (GDM) 是一种怀孕并发症,患病率越来越高,对母亲和孩子的健康造成严重影响.
- 目前用于GDM的诊断方法,如口服葡萄糖耐受性测试,在准确性和实用性方面存在局限性.
- 了解涉及代谢,炎症和表观遗传因素的GDM复杂病原发生至关重要.
研究的目的:
- 审查当前GDM诊断策略及其局限性.
- 探索新兴的预测生物标志物用于早期GDM风险识别.
- 评估用于GDM风险预测的先进机器学习模型.
主要方法:
- 关于GDM诊断和预测方法的综合文献综述.
- 分析目前的查方案 (单步和两步口服葡萄糖耐受性测试).
- 评估新的生物标志物 (代谢,炎症,遗传,胎盘,尿路) 和机器学习模型.
主要成果:
- 新兴的生物标志物,如阿迪波金,血管生成因子和微RNA,对早期GDM检测有希望.
- 与传统方法相比,机器学习模型在预测GDM风险方面表现出更高的准确性.
- 在生物标志物标准化,解决种族差异和验证预测模型方面仍然存在挑战.
结论:
- 需要综合的多原子方法来优化GDM预测和早期诊断.
- 个性化查和管理策略可以改善母亲和孩子的长期结果.
- 进一步的研究对于克服挑战和有效实施先进的预测工具至关重要.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
01:20Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
582
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
582
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
02:46Genetic Screens
5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K
01:15Diabetes: Management and Pharmacotherapy
861
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
861